Growth Metrics

Canton Strategic Holdings (CNTN) Short term Debt (2020 - 2025)

Canton Strategic Holdings posted quarterly Short term Debt of $34376.0 for Q3 2025, down 57.44% year-on-year from $80768.0 in Q3 2024, and down 59.34% on a QoQ basis from $84540.0 in Q2 2025.

Canton Strategic Holdings (CNTN) has 6 years of Short term Debt data on file, last reported at $34376.0 in Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt fell 57.44% year-over-year to $34376.0; the trailing twelve-month figure through Sep 2025 stood at $34376.0 (down 57.44% YoY), and the FY2021 full-year result was $200000.0, changed 0.0% from the prior year.
  • Short term Debt for Q3 2025 stood at $34376.0, down from $84540.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $559917.0 in Q1 2023 and bottomed at $34376.0 in Q3 2025.
  • The 5-year median for Short term Debt is $200000.0 (2021), against an average of $211677.5.
  • The widest annual swing landed in 2023, when Short term Debt surged 179.96%; it then slumped 57.74% in 2025.
  • A 5-year view of Short term Debt shows it stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then plunged by 59.48% to $81040.0 in 2023, then retreated by 0.34% to $80768.0 in 2024, then slumped by 57.44% to $34376.0 in 2025.
  • The last three Short term Debt figures came in at $34376.0 (Q3 2025), $84540.0 (Q2 2025), and $248599.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 34,376.00
Jun 30, 2025 84,540.00
Mar 31, 2025 248,599.00
Sep 30, 2024 80,768.00
Jun 30, 2024 200,048.00
Mar 31, 2024 317,119.00
Sep 30, 2023 81,040.00
Jun 30, 2023 322,046.00
Mar 31, 2023 559,917.00
Mar 31, 2022 200,000.00
Dec 31, 2021 200,000.00
Dec 31, 2020 200,000.00